1a0q:H (VAL2) to (SER112) 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE | CATALYTIC ANTIBODY, ESTERASE
3e8u:H (GLN3) to (SER112) CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION | FAB 106.3, IGG1, BRAIN NATRIURETIC PEPTIDE (BNP), IMMUNE SYSTEM
4web:H (VAL2) to (SER117) STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2 | HEPATITIS C VIRUS, E2, IGG-LIKE FOLD, SCAVENGER RECEPTOR CLASS B TYPE I (SR-BI), CD81, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1nc4:B (LYS3) to (SER118) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA | ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, GADOLINIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
1nc4:C (GLN1) to (VAL108) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA | ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, GADOLINIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
1nc4:D (LYS3) to (VAL117) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA | ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, GADOLINIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
1a6v:H (VAL302) to (VAL418) B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND | IMMUNOGLOBULIN, HAPTEN, IMMUNE SYSTEM
1a7o:H (GLN203) to (VAL314) FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) R96L DELETION MUTANT ON VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL | IMMUNOGLOBULIN, VARIANT, DELETION MUTANT
2aq3:C (ALA3) to (LEU117) CRYSTAL STRUCTURE OF T-CELL RECEPTOR V BETA DOMAIN VARIANT COMPLEXED WITH SUPERANTIGEN SEC3 | T-CELL RECEPTOR V BETA DOMAIN,STAPHLOCOCCAL ENTEROTOXIN C3, COMPLEX STRUCTURE, IMMUNE SYSTEM
4gxu:M (GLN3) to (SER112) CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gxu:O (GLN3) to (SER112) CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4gxv:I (GLN3) to (SER112) CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1 | IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM
2ojz:H (VAL2) to (SER112) ANTI-DNA ANTIBODY ED10 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2ojz:I (VAL2) to (SER112) ANTI-DNA ANTIBODY ED10 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1ad9:H (GLN3) to (SER112) IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01 | IMMUNOGLOBULIN, FAB FRAGMENT
1ad9:B (GLN3) to (SER112) IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01 | IMMUNOGLOBULIN, FAB FRAGMENT
1nld:H (LYS3) to (VAL111) FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1 | FAB FRAGMENT, IMMUNOGLOBULIN
4h0i:A (ILE3) to (SER119) CRYSTAL STRUCTURE OF SCFV-2D10 IN COMPLEX WITH METHYL ALPHA-D- MANNOPYRANOSIDE | SINGLE CHAIN ANTIBODY, MOLECULAR MIMICRY, ANTIGEN RECOGNITION, IMMUNE SYSTEM
2b0s:H (ILE2) to (SER113) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE | FAB-PEPTIDE COMPLEX; HIV-1; GP120; V3 LOOP, IMMUNE SYSTEM
2b1a:H (ILE2) to (SER113) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE | FAB-PEPTIDE COMPLEX; HIV-1; GP120; V3 LOOP, IMMUNE SYSTEM
3rvt:D (GLU1) to (SER120) STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP | IGG, ANTIBODY, DER F 1, DER P 1, IMMUNE SYSTEM
2b1h:H (ILE2) to (SER113) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE | FAB-PEPTIDE COMPLEX; HIV-1; GP120; V3 LOOP, IMMUNE SYSTEM
2otu:B (VAL2) to (SER117) CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX | ANTIBODY FV POLYGLUTAMINE COMPLEX, IMMUNE SYSTEM
2otu:E (LEU2) to (VAL114) CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX | ANTIBODY FV POLYGLUTAMINE COMPLEX, IMMUNE SYSTEM
2otu:G (LEU2) to (VAL114) CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX | ANTIBODY FV POLYGLUTAMINE COMPLEX, IMMUNE SYSTEM
3eo0:B (VAL2) to (VAL118) STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008 | CYTOKINE NEUTRALIZING ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
3eo0:D (VAL2) to (VAL118) STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008 | CYTOKINE NEUTRALIZING ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
4wuk:L (SER2) to (VAL106) CRYSTAL STRUCTURE OF APO CH65 FAB | IMMUNOGLOBULIN
4hcr:H (VAL2) to (SER123) CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659 | IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM
2p47:B (GLN3) to (SER120) COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 2.5A RESOLUTION: SE5B-TRI CRYSTAL FORM WITH FIVE SE-MET SITES (L4M, M34, M51, F68M, M83) IN VHH SCAFFOLD. | SEMET PHASING, CAMELID SINGLE-DOMAIN ANTIBODY, VHH, CAB-RN05, RNASE A, YEAST SURFACE DISPLAY., HYDROLASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
4hjj:H (GLN128) to (SER245) STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE | DFAB COMPLEX, IL-18, DUAL VARIABLE DOMAIN IMMUNOGLOBULIN, IMMUNE SYSTEM
4hk0:A (VAL2) to (SER125) UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
4hk0:C (VAL2) to (SER125) UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
4hk3:J (GLN3) to (VAL124) I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
4hk3:N (GLN1) to (VAL107) I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
3eys:H (VAL2) to (SER122) PFA1 FAB FRAGMENT COMPLEXED WITH PYRO-GLU3-A-BETA (3-8) | FAB, AMYLOID, ALZHEIMER'S, PROTEIN-PEPTIDE COMPLEX, IMMUNE SYSTEM
4hkb:E (VAL2) to (SER125) CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
4hkb:I (VAL2) to (SER125) CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE | FAB FRAGMENT, IMMUNE SYSTEM
2brr:H (VAL2) to (SER112) COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34) | IMMUNE SYSTEM, FAB FRAGMENT, ANTI-PORA ANTIBODY, P1.4 ANTIBODY, ANTIGEN, PORIN, TRANSMEMBRANE, ANTIBODY/ANTIGEN COMPLEX
4x7d:D (ASP1) to (VAL118) CRYSTAL STRUCTURE OF 2012 NSW GII.4 P DOMAIN IN COMPLEX WITH NANO-85 | NANOBODY, VHH DOMAIN, NOROVIRUS, PROTRUDING DOMAIN, VIRAL PROTEIN
2bse:D (GLN3) to (SER123) STRUCTURE OF LACTOCOCCAL BACTERIOPHAGE P2 RECEPTOR BINDING PROTEIN IN COMPLEX WITH A LLAMA VHH DOMAIN | LACTOCOCCUS LACTIS, PHAGE, RECEPTOR BINDING PROTEIN, LLAMA ANTIBODY, VHH, RECEPTOR
4hqq:H (VAL2) to (GLY104) CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58 | IMMUNOGLOBULIN, IMMUNE SYSTEM
1oaq:H (VAL2) to (SER119) FREE CONFORMATION AB1 OF THE IGE SPE-7 | IMMUNE SYSTEM, ALLERGY, IGE, CONFORMATIONAL DIVERSITY, MULTISPECIFICITY
1oar:H (VAL2) to (VAL118) FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED | IMMUNE SYSTEM, ANTIBODY-COMPLEX, ANTIBODY, ALLERGY, IGE, CONFORMATIONAL DIVERSITY, MULTISPECIFICITY
1oar:J (VAL2) to (VAL118) FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED | IMMUNE SYSTEM, ANTIBODY-COMPLEX, ANTIBODY, ALLERGY, IGE, CONFORMATIONAL DIVERSITY, MULTISPECIFICITY
1ob1:B (LEU2) to (SER112) CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19 | IMMUNE SYSTEM, IMMUNOGLOBULIN/COMPLEX, IMMUNOGLOBULIN, ANTIBODY FAB FRAGMENT, MSP1-19, EGF-LIKE DOMAIN, SURFACE ANTIGEN, MALARIA VACCINE COMPONENT
1ob1:E (LEU2) to (SER112) CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19 | IMMUNE SYSTEM, IMMUNOGLOBULIN/COMPLEX, IMMUNOGLOBULIN, ANTIBODY FAB FRAGMENT, MSP1-19, EGF-LIKE DOMAIN, SURFACE ANTIGEN, MALARIA VACCINE COMPONENT
4xak:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD | MERS-COV RBD, ANTIBODY M336, NEUTRALIZATION, IMMUNE SYSTEM
4xbg:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION | HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM
1bz7:B (GLN3) to (SER121) FAB FRAGMENT FROM MURINE ASCITES | ANTIBODY (FAB FRAGMENT), IMMUNE SYSTEM
4hwb:H (VAL3) to (SER118) CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT | FAB, FNIII, CYTOKINE SIGNALING, IMMUNE SYSTEM
4hwe:H (VAL3) to (SER118) CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT | FAB, FNIII, IMMUNE SYSTEM
1c1e:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN | CATALYTIC ANTIBODY, DIELS-ALDER, IMMUNOGLOBULIN, IMMUNE SYSTEM
4hxb:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF 6B9 FAB | ANTIBODY, FAB, COMPLEMENTARITY DETERMINING REGIONS, CARBOHYDRATE- BINDING, IMMUNE SYSTEM
3sdy:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4xhj:H (VAL2) to (SER119) GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES. | COMPLEX, NEUTRALIZATION EPITOPES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1ohq:B (VAL2) to (SER119) CRYSTAL STRUCTURE OF HEL4, A SOLUBLE HUMAN VH ANTIBODY DOMAIN RESISTANT TO AGGREGATION | ANTIBODY, IMMUNE SYSTEM, FV FRAGMENT, HEL4, IMMUNOGLOBULIN
1cf8:H (VAL2) to (SER112) CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS | CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION CASCADE
3fo2:H (VAL2) to (VAL119) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3fo2:B (VAL2) to (VAL119) CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT) | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3sqo:H (GLN3) to (SER112) PCSK9 J16 FAB COMPLEX | CHOLESTEROL REGULATION, LDLR, HYDROLASE-IMMUNE SYSTEM COMPLEX
1ct8:D (VAL2) to (SER112) CATALYTIC ANTIBODY 7C8 COMPLEX | ABZYME TRANSITION STATE ANALOG, IMMUNE SYSTEM
2q8a:H (GLN3) to (SER111) STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM
1dba:H (GLN3) to (SER112) THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX | IMMUNOGLOBULIN
1dbb:H (GLN3) to (SER112) THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX | IMMUNOGLOBULIN
4iml:H (GLN3) to (SER128) CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2 | CROSSFAB, ANTIGEN BINDING, HUMAN ANGIOPOIETIN 2, IMMUNE SYSTEM
4iml:A (GLN3) to (SER128) CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2 | CROSSFAB, ANTIGEN BINDING, HUMAN ANGIOPOIETIN 2, IMMUNE SYSTEM
1pew:A (ASN1) to (VAL106) HIGH RESOLUTION CRYSTAL STRUCTURE OF JTO2, A MUTANT OF THE NON- AMYLOIDOGENIC LAMBA6 LIGHT CHAIN, JTO | BETA SHEET, IMMUNE SYSTEM
3t2n:H (VAL2) to (SER112) HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY | TYPE II TRANSMEMBRANE SERINE PROTEASE, SRCR DOMAIN, SUBSTRATES INCLUDE PRO-HEPSIN, PRO-HGF, LAMININ-332, TRANSMEMBRANE, HYDROLASE
3t2n:I (VAL2) to (SER112) HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY | TYPE II TRANSMEMBRANE SERINE PROTEASE, SRCR DOMAIN, SUBSTRATES INCLUDE PRO-HEPSIN, PRO-HGF, LAMININ-332, TRANSMEMBRANE, HYDROLASE
4xvu:C (GLN6) to (SER121) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xvu:I (GLN6) to (SER121) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4isv:B (ILE2) to (SER120) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE | 1C2,FAB, VLX, NEURODEGENERATION, POLYGLUTAMINE DISEASE, AMYLOID DISEASE, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1dqd:H (GLU1) to (SER121) CRYSTAL STRUCTURE OF FAB HGR-2 F6, A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR | GLUCAGON RECEPTOR, MONOCLONAL ANTIBODY, FAB, RECEPTOR ANTAGONIST, TYPICAL IMMUNOGLOBULIN FOLD, LIGHT CHAIN, HEAVY CHAIN, ANTIGEN BINDING SITE, COMPLEMENTARITY-DETERMINING REGIONS, IMMUNE SYSTEM
2d03:H (GLN3) to (SER118) CRYSTAL STRUCTURE OF THE G91S MUTANT OF THE NNA7 FAB | ANTIBODY, IMMUNE SYSTEM
4xzu:A (ILE2) to (SER115) CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY | IMMUNOGLOBULIN, BLOOD COAGULATION, ANTIBODY, DISCOIDIN, IMMUNE SYSTEM
4xzu:E (ILE2) to (SER115) CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY | IMMUNOGLOBULIN, BLOOD COAGULATION, ANTIBODY, DISCOIDIN, IMMUNE SYSTEM
4j1u:B (GLN3) to (VAL115) CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT | ANTIBODY MATURATION, ANTIBODY STABILITY, CLONAL SELECTION, IMMUNE SYSTEM
4j1u:F (GLN3) to (SER116) CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT | ANTIBODY MATURATION, ANTIBODY STABILITY, CLONAL SELECTION, IMMUNE SYSTEM
2dbl:H (GLN3) to (SER112) MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY | IMMUNOGLOBULIN
1e6o:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24 | IMMUNOGLOBULIN, FAB, ANTIBODY, ANTIGEN, HIV-1, P24, CA
1q1j:H (GLN3) to (SER112) CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE | FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNE SYSTEM
1eap:B (VAL2) to (SER123) CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE | CATALYTIC ANTIBODY
4jdt:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF CHIMERIC GERM-LINE PRECURSOR OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV-1 | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
4jdv:A (VAL2) to (SER116) CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB | IG FOLD, ANTI HIV ANTIBODY, IMMUNE SYSTEM
4jdv:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB | IG FOLD, ANTI HIV ANTIBODY, IMMUNE SYSTEM
1q9l:B (VAL2) to (VAL109) S25-2 FAB UNLIGANDED 2 | ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM
3tnm:A (GLN3) to (SER112) CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY | ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, FAB, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM
4jfy:H (VAL2) to (SER112) APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD | IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1qbl:H (VAL2) to (SER116) FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION | IMMUNOGLOBULIN, IGG1 KAPPA, ANTIBODY, FAB FRAGMENT, ANTI- CYTOCHROME C ANTIBODY
1qbm:H (VAL2) to (VAL115) FAB E8B ANTIBODY, X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN, IGG1 KAPPA, ANTIBODY, FAB FRAGMENT, ANTI- CYTOCHROME C ANTIBODY
4jj5:B (GLN3) to (SER120) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE | 1C2, VLX, NEURODEGENERATION, POLYGLUTAMINE DISEASE, AMYLOID DISEASE, IMMUNOGLOBULIN FOLD, POLYGLUTAMINE, IMMUNE SYSTEM
4ydl:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
3tt1:H (VAL2) to (SER120) CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB | LEUT FOLD, TRANSPORTER, PLASMA MEMBRANE, TRANSPORT PROTEIN
3tt1:I (VAL2) to (SER120) CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB | LEUT FOLD, TRANSPORTER, PLASMA MEMBRANE, TRANSPORT PROTEIN
3h3b:D (VAL136) to (SER253) CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV (SCFV) FRAGMENT OF AN ANTI- ERBB2 ANTIBODY CHA21 IN COMPLEX WITH RESIDUES 1-192 OF ERBB2 EXTRACELLULAR DOMAIN | IMMUNOGLOBULIN, BETA-HELIX, PROTEIN-PROTEIN COMPLEX, ATP-BINDING, DISULFIDE BOND, KINASE, NUCLEOTIDE-BINDING, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, IMMUNE SYSTEM
4jpv:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, CD4-BINDING SITE, 3BNC117, NEUTRALIZATION, VACCINE, ANTIBODY, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4jr9:H (ILE2) to (SER117) CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK | TRANSPORTER, IMMUNOGLOBULIN, MAJOR FACILITATOR SUPERFAMILY, EXCHANGER, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4jre:B (ILE2) to (SER117) CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND | TRANSPORTER, IMMUNOGLOBULIN, MAJOR FACILITATOR SUPERFAMILY, EXCHANGER, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4jre:H (ILE2) to (SER117) CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND | TRANSPORTER, IMMUNOGLOBULIN, MAJOR FACILITATOR SUPERFAMILY, EXCHANGER, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4jre:L (LEU3) to (ALA108) CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND | TRANSPORTER, IMMUNOGLOBULIN, MAJOR FACILITATOR SUPERFAMILY, EXCHANGER, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4jry:E (VAL4) to (THR126) CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX | TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM
3hc0:H (VAL2) to (SER115) BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR | IGG1 FAB, BHA10, IMMUNE SYSTEM
3hc0:A (VAL2) to (SER115) BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR | IGG1 FAB, BHA10, IMMUNE SYSTEM
3hc3:H (VAL2) to (SER115) BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR | IGG1 FAB, BHA10, IMMUNE SYSTEM
2eh7:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB | HEPATITIS B VIRUS, HUMANIZED ANTIBODY, MONOCLONAL ANTIBODY, NEUTRALIZATION, PRES1, IMMUNE SYSTEM
1fdl:H (VAL2) to (SER115) CRYSTALLOGRAPHIC REFINEMENT OF THE THREE-DIMENSIONAL STRUCTURE OF THE FAB D1.3-LYSOZYME COMPLEX AT 2.5- ANGSTROMS RESOLUTION | COMPLEX (ANTIBODY-ANTIGEN)
1fe8:H (LYS3) to (SER114) CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING | COLLAGEN BINDING, CONFORMATIONAL CHANGES, EPITOPE, VON WILLEBRAND FACTOR A-TYPE DOMAIN, IMMUNE SYSTEM
4jzn:A (GLN1) to (SER118) THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1 | FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1fgn:H (ILE2) to (SER116) MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR | ANTIBODY, FAB, ANTI-TF, MONOCLONAL, MURINE, IMMUNOGLOBULIN
4ypg:B (VAL2) to (SER115) STRUCTURAL INSIGHTS INTO THE NEUTRALIZATION PROPERTIES OF A HUMAN ANTI-INTERFERON MONOCLONAL ANTIBODY | THERAPEUTIC MAB, IFN-ALPHA2A
4ypg:H (VAL2) to (SER115) STRUCTURAL INSIGHTS INTO THE NEUTRALIZATION PROPERTIES OF A HUMAN ANTI-INTERFERON MONOCLONAL ANTIBODY | THERAPEUTIC MAB, IFN-ALPHA2A
3hi6:X (GLN3) to (SER119) CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57 | INTEGRIN, I DOMAIN, FAB, LIGAND MIMETIC ANTIBODY, CELL ADHESION, ALTERNATIVE SPLICING, CALCIUM, DISULFIDE BOND, GLYCOPROTEIN, MAGNESIUM, MEMBRANE, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, CELL ADHESION/IMMUNE SYSTEM COMPLEX
4k3h:E (GLN1) to (LEU106) IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN | IMMUNOGLOBULIN FOLD, FLUORESCENSCE, MALACHITE GREEN, O-MANNOSYLATION, THR27, IMMUNE SYSTEM-INHIBITOR COMPLEX
4k3h:H (GLN1) to (LEU106) IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN | IMMUNOGLOBULIN FOLD, FLUORESCENSCE, MALACHITE GREEN, O-MANNOSYLATION, THR27, IMMUNE SYSTEM-INHIBITOR COMPLEX
3uji:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2558 IN COMPLEX WITH MN PEPTIDE | IG DOMAINS, ANTIBODY FAB, ANTIGEN BINDING, THE THIRD VARIABLE REGION OF HIV-1 GP120, IMMUNE SYSTEM
2f19:H (GLN1) to (SER123) THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY | IMMUNOGLOBULIN
4yx2:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF BOVINE PRION PROTEIN COMPLEXED WITH POM1 FAB | PRION, ANTIBODY, COMPLEX, IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM
3ulu:H (VAL2) to (SER120) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1) | TOLL-LIKE RECEPTOR-3, TLR3,INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ulv:H (VAL2) to (SER120) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2) | TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
2vc2:H (VAL2) to (SER118) RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758 | CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE,
4z0x:A (TYR2) to (LEU106) STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 434-446 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC26AM | HCV, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
1g7h:B (VAL2) to (SER116) CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3(VLW92A) | HYDROLASE INHIBITOR/HYDROLASE
1rzf:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51 | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:H (GLN3) to (ALA112) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:J (VAL2) to (ALA112) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
3utp:K (LYS2) to (ARG110) 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA | T CELL RECEPTOR, TYPE I DIABETES, IMMUNE SYSTEM
1ggb:H (GLN3) to (SER112) MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY | IMMUNOGLOBULIN
1s5i:H (GLN3) to (SER112) FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2, CRYSTAL STRUCTURE | MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, X-RAY ANALYSIS, CRYSTAL STRUCTURE, IMMUNE SYSTEM
1ggi:H (VAL2) to (VAL111) CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN | IMMUNOGLOBULIN
1ggi:J (VAL2) to (SER112) CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN | IMMUNOGLOBULIN
4zd3:H (GLN3) to (SER127) STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY FAB FRAGMENT | TRANSGLUTAMINASE 2, ANTIBODY, FAB FRAGMENT, CELIAC DISEASE, IMMUNE SYSTEM
3v0v:H (VAL2) to (SER112) FAB WN1 222-5 UNLIGANDED | BETA SHEETS, ANTIBODY, FAB, IMMUNE SYSTEM
3v7a:F (VAL2) to (SER119) STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE | VIRUS, PROTEIN-FAB COMPLEX, BROADLY-REACTIVE ANTIBODY, IMMUNE SYSTEM
3v7a:E (VAL2) to (SER119) STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE | VIRUS, PROTEIN-FAB COMPLEX, BROADLY-REACTIVE ANTIBODY, IMMUNE SYSTEM
2vq1:B (THR3) to (VAL111) ANTI TRIMERIC LEWIS X FAB54-5C10-A | MONOCLONAL ANTIBODY, RECEPTOR, DIAGNOSIS, SCHISTOSOMIASIS, CARBOHYDRATE RECOGNITION, IMMUNE SYSTEM
2vq1:F (ILE2) to (VAL111) ANTI TRIMERIC LEWIS X FAB54-5C10-A | MONOCLONAL ANTIBODY, RECEPTOR, DIAGNOSIS, SCHISTOSOMIASIS, CARBOHYDRATE RECOGNITION, IMMUNE SYSTEM
4kv5:J (VAL2) to (SER119) SCFV GC1009 IN COMPLEX WITH TGF-BETA1. | CYSTEINE KNOT, FAB, TGF-BETA RECEPTOR MIMETIC, TGF-BETA, TGF-BETA RECEPTOR, IMMUNE SYSTEM
4kv5:H (VAL2) to (SER119) SCFV GC1009 IN COMPLEX WITH TGF-BETA1. | CYSTEINE KNOT, FAB, TGF-BETA RECEPTOR MIMETIC, TGF-BETA, TGF-BETA RECEPTOR, IMMUNE SYSTEM
4kv5:G (VAL2) to (SER119) SCFV GC1009 IN COMPLEX WITH TGF-BETA1. | CYSTEINE KNOT, FAB, TGF-BETA RECEPTOR MIMETIC, TGF-BETA, TGF-BETA RECEPTOR, IMMUNE SYSTEM
2g75:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY | SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM
2g75:C (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY | SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM
2vwe:L (GLN3) to (VAL111) CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT | IMMUNE SYSTEM, GLYCOPROTEIN, CYSTEINE-KNOT, GROWTH FACTOR, VEGF-B, MITOGEN, SECRETED, ANGIOGENESIS, NEUTRALIZING ANTIBODY, HEPARIN-BINDING, ALTERNATIVE SPLICING
2vxt:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB | FAB, IL-18, SECRETED, CYTOKINE, AUTOIMMUNITY, GLYCOPROTEIN, TH1/TH2 CELLS, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
2vxv:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT | IMMUNE SYSTEM, IL-18, FAB, TH1/TH2 CELLS, AUTOIMMUNITY
3vg0:H (LYS5) to (VAL117) ANTIBODY FAB FRAGMENT | ANTIBODY FAB FRAGMENT, IMMUNOGLOBULIN FOLD, N-LINKED GLYCOSYLATION SITE, FAB FRAGMENT, LBD DOMAIN OF OBR RECEPTOR, IMMUNE SYSTEM
1t2q:H (GLN3) to (SER118) THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N-TYPE BLOOD GROUP ANTIGEN | FAB, GLYCOPHORIN A, BLOOD GROUP ANTIGEN, IMMUNE SYSTEM
2gjz:H (GLN3) to (SER112) STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1) | IMMUNOGLOBULIN,CATALYTIC ANTIBODY, ELIMINATION, IMMUNE SYSTEM
2gjz:B (GLN3) to (SER112) STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1) | IMMUNOGLOBULIN,CATALYTIC ANTIBODY, ELIMINATION, IMMUNE SYSTEM
1t3f:B (VAL2) to (SER116) THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP | ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODY, FAB, X-RAY STRUCTURE, GAMMA-INTERFERON, IMMUNE SYSTEM
1h3p:H (VAL2) to (SER112) STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS | IMMUNOGLOBULIN, ANTIBODY FAB FRAGMENT
1t4k:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB | ENANTIOSELECTIVITY, ALDOLASE ANTIBODY, REACTIVE LYSINE, ALDOL REACTION, IMMUNE SYSTEM
1t4k:D (VAL2) to (SER112) CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB | ENANTIOSELECTIVITY, ALDOLASE ANTIBODY, REACTIVE LYSINE, ALDOL REACTION, IMMUNE SYSTEM
3idm:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS | HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM
2w0f:A (GLN3) to (SER117) POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM | IMMUNE SYSTEM METAL TRANSPORT COMPLEX, QUATERNARY AMMONIUM, PROTEIN-ANTIBODY FAB COMPLEX, IONIC CHANNEL, ION TRANSPORT, POTASSIUM CHANNEL
3if1:C (ILE2) to (ILE106) CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC | GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM
2gsi:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE | FAB, IGG, STAPHYLOCOCCAL NUCLEASE, IMMUNE SYSTEM
4lci:H (ILE2) to (SER110) ANTI CANINE CD28 ANTIBODY, 1C6 | IMMUNOGLOBULIN, ANTIBODY, CD28, IMMUNE SYSTEM
2w60:A (ILE2) to (SER117) ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 | ANTIBODY ANTI-CITRULLIN, ARTHRITIS, IMMUNE SYSTEM
2w65:A (ILE2) to (SER117) ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE | ARTHRITIS, COLLAGEN TYPE II, ANTIBODY ANTI-CITRULLIN, IMMUNE SYSTEM
2w65:C (ILE2) to (SER117) ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE | ARTHRITIS, COLLAGEN TYPE II, ANTIBODY ANTI-CITRULLIN, IMMUNE SYSTEM
2h32:H (GLN3) to (SER118) CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR | BETA SHEETS, V AND C-TYPE IG FOLDS, IMMUNE SYSTEM
4liq:H (VAL2) to (SER115) STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CSF-1 RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF RG7155 | CSF-1 RECEPTOR, RECEPTOR TYROSINE KINASE, ANTIBODY, FAB FRAGMENT, IGG LIKE DOMAIN, IMMUNE SYSTEM
1tpx:B (ILE2) to (SER112) OVINE RECOMBINANT PRP(114-234), ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY | PRION, ANTIBODY, UNKNOWN FUNCTION
1hq4:D (ASP1) to (SER112) STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4 | CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION CASCADE, IMMUNOGLOBULIN, IMMUNE SYSTEM
1tvd:B (LYS2) to (GLU115) VARIABLE DOMAIN OF T CELL RECEPTOR DELTA CHAIN | IMMUNORECEPTOR, TCR, DELTA CHAIN, VARIABLE DOMAIN
4llv:A (GLN3) to (VAL111) THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV | 4E10, FV, HIV, IMMUNOGLOBULIN, ANTIBODY, IMMUNE SYSTEM
4llv:C (VAL2) to (VAL111) THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV | 4E10, FV, HIV, IMMUNOGLOBULIN, ANTIBODY, IMMUNE SYSTEM
3vrl:H (VAL2) to (SER121) CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB | HIV-1 CAPSIDE P24, CAPSID PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1tzh:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF | PHAGE DISPLAY, ANTIBODY LIBRARY, PROTEIN ENGINEERING, IMMUNE SYSTEM
1u0q:A (PCA1) to (SER112) STRUCTURE OF A LLAMA VHH DOMAIN RAISED AGAINST A CARBAZOLE MOLECULE | IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
1u0q:B (PCA201) to (SER312) STRUCTURE OF A LLAMA VHH DOMAIN RAISED AGAINST A CARBAZOLE MOLECULE | IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3vxu:J (VAL4) to (THR111) THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE | HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE
3w11:C (VAL2) to (VAL116) INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HUMAN INSULIN, ALPHA-CT PEPTIDE(704-719) AND FAB 83-7 | CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX
3w12:C (VAL2) to (VAL116) INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2, ALPHA-CT PEPTIDE(704-719) AND FAB 83-7 | CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE RECEPTOR-HORMONE-IMMUNE SYSTEM COMPLEX
3w13:C (VAL2) to (VAL116) INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2, ALPHACT PEPTIDE(693-719) AND FAB 83-7 | CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN ANALOGUE, HORMONE RECEPTOR-HORMONE-IMMUNE SYSTEM COMPLEX
3w2d:H (VAL20) to (GLY130) CRYSTAL STRUCTURE OF STAPHYLOCOCCAL EENTEROTOXIN B IN COMPLEX WITH A NOVEL NEUTRALIZATION MONOCLONAL ANTIBODY FAB FRAGMENT | STAPHYLOCOCCAL EENTEROTOXIN B, IMMUNE SYSTEM
5a3i:C (VAL2) to (SER124) CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ | VIRAL PROTEIN, HAEMAGGLUTININ, NEUTRALIZING ANTIBODY, BIRD FLU, H5N1, INFLUENZA VIRUS, GLYCOPROTEIN
5a3i:G (VAL2) to (SER124) CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ | VIRAL PROTEIN, HAEMAGGLUTININ, NEUTRALIZING ANTIBODY, BIRD FLU, H5N1, INFLUENZA VIRUS, GLYCOPROTEIN
1iai:I (GLU1) to (SER120) IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX | COMPLEX (IMMUNOGLOBULIN IGG1/IGG2A)
1ibg:H (HIS3) to (SER112) STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50 | IMMUNOGLOBULIN, FAB, COMPLEX, IMMUNE SYSTEM
2i5y:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2i5y:R (VAL2) to (SER112) CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2i60:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, [PHE23]M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4m3j:B (GLN1) to (SER119) STRUCTURE OF A SINGLE-DOMAIN CAMELID ANTIBODY FRAGMENT CAB-H7S SPECIFIC OF THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS | IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, BETA-LACTAMASE BINDING ANTIBODY, IMMUNE SYSTEM
1il1:A (GLN3) to (SER120) CRYSTAL STRUCTURE OF G3-519, AN ANTI-HIV MONOCLONAL ANTIBODY | FAB, BETA SHEET STRUCTURE, ANTIBODY, IMMUNE SYSTEM
3w9d:A (THR3) to (SER121) STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB | IGG FOLD, HSV GD, IMMUNE SYSTEM
3w9d:C (THR3) to (SER121) STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB | IGG FOLD, HSV GD, IMMUNE SYSTEM
3w9e:A (THR3) to (SER121) STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD | IGG FOLD, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1um5:H (VAL3) to (SER118) CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE | CATALYTIC ANTIBODY LIGAND TRANSESTERIFICATION, IMMUNE SYSTEM
4m6m:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
4m6n:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
5aam:A (VAL3) to (SER115) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | IMMUNE SYSTEM, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
5aam:B (GLN4) to (SER115) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | IMMUNE SYSTEM, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
5aaw:A (GLN4) to (SER115) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | VIRAL PROTEIN, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
5aaw:B (GLN4) to (SER115) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | VIRAL PROTEIN, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
5aaw:D (GLN4) to (SER115) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | VIRAL PROTEIN, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
5aaw:F (GLN4) to (SER115) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | VIRAL PROTEIN, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
5aaw:H (GLN4) to (SER115) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | VIRAL PROTEIN, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
5aaw:K (GLN4) to (SER115) STRUCTURE OF A REDESIGNED CROSS-REACTIVE ANTIBODY TO DENGUE VIRUS WITH INCREASED IN VIVO POTENCY | VIRAL PROTEIN, SCFV DENGUE ANTIBODY ENVELOPE DOMAIN III
4ma3:H (PCA1) to (SER113) CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
4ma3:B (PCA1) to (SER113) CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
1j05:H (VAL2) to (SER112) THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT | IMMUNOGLOBULIN, IMMUNE SYSTEM
1uz6:F (VAL2) to (VAL111) ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED | IMMUNE SYSTEM, ANTIBODY/COMPLEX, ANTIBODY, ANTI-CARBOHYDRATE
1uz6:W (VAL2) to (VAL111) ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED | IMMUNE SYSTEM, ANTIBODY/COMPLEX, ANTIBODY, ANTI-CARBOHYDRATE
1uz8:B (VAL2) to (VAL111) ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X | IMMUNE SYSTEM, ANTIBODY, ANTI-CARBOHYDRATE
2ipt:H (VAL2) to (SER112) PFA1 FAB FRAGMENT | WWDDD, CDR, ABETA, IMMUNE SYSTEM
2iqa:H (VAL2) to (SER112) PFA2 FAB FRAGMENT, MONOCLINIC APO FORM | PFA2, WWDDD, CDR, IMMUNE SYSTEM
2iqa:B (GLN1) to (SER112) PFA2 FAB FRAGMENT, MONOCLINIC APO FORM | PFA2, WWDDD, CDR, IMMUNE SYSTEM
3wkm:H (VAL2) to (SER122) THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT | PDZ DOMAIN, HYDROLASE
3wkm:I (VAL2) to (SER122) THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT | PDZ DOMAIN, HYDROLASE
5alb:H (VAL2) to (SER112) TICAGRELOR ANTIDOTE CANDIDATE MEDI2452 IN COMPLEX WITH TICAGRELOR | IMMUNE SYSTEM, ANTIBODY FRAGMENT, ANTIDOTE, DRUG
5anm:B (VAL2) to (SER120) CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY | IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA
5anm:C (LEU4) to (GLY112) CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY | IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA
5any:I (ILE2) to (SER112) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
5any:J (ILE2) to (SER112) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
5any:K (ILE2) to (SER112) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
5any:L (ILE2) to (SER112) ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265 | VIRUS, CHIKUNGUNYA VIRUS, NEUTRALIZING ANTIBODY FAB
1jhk:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE ANTI-ESTRADIOL ANTIBODY 57-2 | ANTIBODY, STEROID, IMMUNE SYSTEM
1jn6:B (VAL2) to (VAL117) CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES | IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM
3wv0:A (GLY34) to (ILE149) O-GLYCAN ATTACHED TO HERPES SIMPLEX VIRUS TYPE 1 GLYCOPROTEIN GB IS RECOGNIZED BY THE IG V-SET DOMAIN OF HUMAN PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR ALPHA | IMMUNOGLOBULIN-LIKE, IMMUNOLOGICAL RECEPTOR, MEMBRANE, MEMBRANE PROTEIN
1jrh:H (LYS3) to (SER112) COMPLEX (ANTIBODY/ANTIGEN) | CYTOKINE RECEPTOR, COMPLEX (ANTIBODY/ANTIGEN), TRANSMEMBRANE, GLYCOPROTEIN
2j88:H (VAL2) to (SER111) HYALURONIDASE IN COMPLEX WITH A MONOCLONAL IGG FAB FRAGMENT | GLYCOPROTEIN, GLYCOSIDASE FAMILY 56, ZYMOGEN, ALLERGEN, 7- STRANDED (BETA/ALPHA) TIM BARREL, HYDROLASE, GLYCOSIDASE, IMMUNOGLOBULIN DOMAIN
4mxv:F (VAL2) to (SER112) STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB | TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX
3wxv:H (VAL2) to (SER117) CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1 | PAQR FAMILY, ADIPONECTIN, OSMOTIN, APPL1, APPL2, MEMBRANE, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
3wxw:H (VAL2) to (VAL116) CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2 | PAQR FAMILY, GLUCOSE AND LIPID METABOLISM, ADIPONECTIN, OSMOTIN, APPL1, APPL2, MEMBRANE, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
1jv5:B (VAL302) to (SER417) ANTI-BLOOD GROUP A FV | IMMUNOGLOBULIN, IMMUNE SYSTEM, SUGAR BINDING PROTEIN
5aze:H (VAL2) to (SER120) FAB FRAGMENT OF CALCIUM-DEPENDENT ANTIGEN BINDING ANTIBODY, 6RL#9 | CALCIUM-DEPENDENT, RECYCLING ANTIBODY, IMMUNE SYSTEM
3x2d:D (GLN3) to (SER127) CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78 | MARBURG, GLYCOPROTEIN, ANTIBODY, VIRUS, NEUTRALIZATION, FUSION, NIEMANN PICK C1 (NPC1) RECEPTOR, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3x2d:L (GLN1) to (SER127) CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78 | MARBURG, GLYCOPROTEIN, ANTIBODY, VIRUS, NEUTRALIZATION, FUSION, NIEMANN PICK C1 (NPC1) RECEPTOR, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2jb6:B (GLN3) to (SER119) FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2 | CDR, TSC, FAB, HUCAL, FLUORESCENT DYE, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, DIAGNOSTIC IMAGING, IMMUNE SYSTEM
3x3g:H (VAL2) to (SER125) FAB FRAGMENT FROM ANTI TRAIL-R2 HUMAN AGONIST ANTIBODY KMTR2 | AGONIST ANTIBODY, ANTI TRAIL-R2, IMMUNE SYSTEM
5b8c:B (VAL2) to (SER119) HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV | ANTIBODY, IMMUNE SYSTEM
5b8c:E (GLN3) to (SER119) HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV | ANTIBODY, IMMUNE SYSTEM
5b8c:H (VAL2) to (VAL118) HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV | ANTIBODY, IMMUNE SYSTEM
5bo1:H (VAL2) to (VAL114) CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB | JAG, NOTCH, ANTAGONIST, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5bo1:I (VAL2) to (VAL114) CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB | JAG, NOTCH, ANTAGONIST, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
4n90:D (GLN1) to (SER121) CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL, DR5, AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY | DR5, TRAIL, AGONIST, ANTIBODY, COOPERATION, CLUSTERING, APOPTOSIS- IMMUNE SYSTEM COMPLEX
2xwt:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY | SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX, GPCR, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR-AUTOANTIBODY COMPLEX
1wc7:B (VAL2) to (SER112) FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE | ANTIBODY, CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, PHOSPHOPYRIDOXYL-L-ALANINE
5bvp:H (VAL2) to (SER117) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, CYTOKINE, BETA TREFOIL, IMMUNE SYSTEM
4nhu:D (ALA3) to (LEU110) THE M33 TCR P3M33L/H-2 LD COMPLEX | IG, TCR, MHC, ANTIGEN, IMMUNE SYSTEM
3zkm:C (GLN3) to (SER115) BACE2 FAB COMPLEX | HYDROLASE-IMMUNE SYSTEM COMPLEX, HYDROLASE, ASPARTYL PROTEASE/FAB COMPLEX
1kcr:H (GLN1) to (VAL114) CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE | ANTIBODY, PEPTIDE ANTIGEN COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM
1kcs:H (GLN1) to (SER115) CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE | ANTIBODY, PEPTIDE ANTIGEN COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM
2kqm:B (GLN203) to (GLU305) SOLUTION STRUCTURE OF THE KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN | AMYLOIDOSIS, IMMUNOGLOBULIN KAPPA LIGHT CHAIN, HOMODIMER, BENCE-JONES PROTEIN, DISULFIDE BOND, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION, IMMUNE SYSTEM
4nm4:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 | IMMUNE SYSTEM, IMMUNE RECOGNITION, ANTIBODY, FAB, IMMUNOGLOBULIN, INFLUENZA HEMAGGLUTININ
4nm4:I (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 | IMMUNE SYSTEM, IMMUNE RECOGNITION, ANTIBODY, FAB, IMMUNOGLOBULIN, INFLUENZA HEMAGGLUTININ
4nm8:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNOGLOBULIN'
4nm8:I (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNOGLOBULIN'
4nm8:J (VAL2) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ | VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNOGLOBULIN'
1kir:B (VAL2) to (SER116) FV MUTANT Y(A 50)S (VL DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME | IMMUNOGLOBULIN V REGION, SIGNAL, HYDROLASE, GLYCOSIDASE, BACTERIOLYTIC ENZYME, EGG WHITE, COMPLEX (IMMUNOGLOBULIN/HYDROLASE)
4np4:H (VAL2) to (SER118) CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB | BEZLOTOXUMAB, HUMAN ANTIBODY, FAB, CROP DOMAIN, CYTOTOXIN, SHORT REPEAT, LONG REPEAT, TCDB, RECEPTOR BINDING, IMMUNE SYSTEM
4np4:I (VAL2) to (SER118) CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB | BEZLOTOXUMAB, HUMAN ANTIBODY, FAB, CROP DOMAIN, CYTOTOXIN, SHORT REPEAT, LONG REPEAT, TCDB, RECEPTOR BINDING, IMMUNE SYSTEM
4npy:L (TYR2) to (VAL106) CRYSTAL STRUCTURE OF GERMLINE FAB PGT121, A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | IGG-FOLD, ANTI-HIV ANTIBODY PRECURSOR, HIV ENV GP120, IMMUNE SYSTEM
4npy:A (TYR2) to (VAL106) CRYSTAL STRUCTURE OF GERMLINE FAB PGT121, A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | IGG-FOLD, ANTI-HIV ANTIBODY PRECURSOR, HIV ENV GP120, IMMUNE SYSTEM
1kno:D (VAL2) to (SER118) CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES | CATALYTIC ANTIBODY
3ztn:H (VAL2) to (SER112) STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H1 INFLUENZA HAEMAGGLUTININ. | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, MONOCLONAL ANTIBODY.
5c7k:E (ILE2) to (SER112) CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195 | HIV-1, SOSIP, PGT128, 8ANC195, IMMUNE SYSTEM
1kxq:E (GLN1) to (SER119) CAMELID VHH DOMAIN IN COMPLEX WITH PORCINE PANCREATIC ALPHA- AMYLASE | ALPHA 8 BETA 8, BETA BARREL, HYDROLASE, IMMUNE SYSTEM
1xcq:D (ILE2) to (SER117) COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A,L57H,Y64W) IN SPACE GROUP P21 | CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM
1xct:B (ILE2) to (SER117) COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A, L57H, Y64W) IN SPACE GROUP P21212 | CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM
1xct:D (GLN3) to (SER117) COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A, L57H, Y64W) IN SPACE GROUP P21212 | CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM
4nzt:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB | LEUCINE-RICH REPEAT, BROAD ANTIBODY-BINDING, BLOCK ANTIBODY-ANTIGEN UNION, VARIABLE REGION, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
4o02:H (VAL2) to (SER117) ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT. | PROTEIN BINDING
1xf5:B (ILE2) to (SER117) COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C, Y64W)IN SPACE GROUP P21212 | CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM
43ca:D (GLN1) to (SER112) CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL | IMMUNOGLOBULIN, CATALYTIC ANTIBODY
43c9:H (GLN1) to (SER112) CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY | IMMUNOGLOBULIN
4o58:H (GLU1) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/3/1975 (H3N2) INFLUENZA HEMAGGLUTININ | IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3jwd:H (VAL2) to (SER112) STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY | HIV-1 VIRAL SPIKE, MOLECULAR MOTION, PROTEIN ARCHITECTURE, RECEPTOR- TRIGGERED ENTRY, TYPE 1 FUSION PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, VIRAL PROTEIN
4oaw:B (VAL2) to (SER112) FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
4ocm:F (GLN4) to (SER122) CRYSTAL STRUCTURE OF THE RPN8-RPN11 MPN DOMAIN HETERODIMER, CRYSTAL FORM IB | 26S PROTEASOME, ISOPEPTIDASE ACTIVITY, REGULATORY PARTICLE, LID, UBIQUITIN, HYDROLASE, PROTEIN BINDING
2ny5:H (GLU3001) to (SER3127) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2nyy:D (GLN3) to (SER117) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1 | BOTULINUM, NEUROTOXIN, FAB, PROTEIN ANTIBODY COMPLEX, TOXIN-IMMUNE SYSTEM COMPLEX
4oga:C (VAL2) to (VAL116) INSULIN IN COMPLEX WITH SITE 1 OF THE HUMAN INSULIN RECEPTOR | CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, CT PEPTIDE, INSULIN, HORMONE RECEPTOR-HORMONE-IMMUNE SYSTEM COMPLEX
2z31:A (ASP1) to (VAL115) CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX | IMMUNE SYSTEM, COMPLEX
4ogx:H (GLU1) to (SER121) CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.4 ANGSTROM RESOLUTION | FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN- MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, HMWK, SERPIN C1-INHIBITOR, C1-INH, HEREDITARY ANGIOEDEMA, HAW, BRADYKININ, FLETCHER FACTOR, KININOGENIN, SERINE PROTEASE, EDEMA, HYDROLASE-ANTIBODY COMPLEX
4ogy:M (VAL2) to (SER121) CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.1 ANGSTROM RESOLUTION | FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN- MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, HMWK, SERPIN C1-INHIBITOR, C1-INH, HEREDITARY ANGIOEDEMA, HAW, BRADYKININ, FLETCHER FACTOR, KININOGENIN, SERINE PROTEASE, EDEMA, HYDROLASE-ANTIBODY COMPLEX
5cma:B (VAL2) to (SER117) ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT | B7-H3 8H9 MONOCLONAL ANTIBODY, IMMUNE SYSTEM
1lmk:A (VAL2) to (SER121) THE STRUCTURE OF A BIVALENT DIABODY | IMMUNOGLOBULIN, DIABODY, SINGLE-CHAIN FV, SCFV
1lmk:G (VAL2) to (SER121) THE STRUCTURE OF A BIVALENT DIABODY | IMMUNOGLOBULIN, DIABODY, SINGLE-CHAIN FV, SCFV
2o5x:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP, AN ENGINEERED DIELS- ALDERASE FAB WITH NM STEROID-BINDING AFFINITY | IMMUNOGLOBULIN, CHIMERIC FAB, ANTIBODY ENGINEERING, EVOLUTION OF LIGAND RECOGNITION, IMMUNE SYSTEM
2o5y:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX | IMMUNOGLOBULIN, CHIMERIC FAB, ANTIBODY ENGINEERING, EVOLUTION OF LIGAND RECOGNITION, IMMUNE SYSTEM
2o5z:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-3,17-DIONE COMPLEX | IMMUNOGLOBULIN, CHIMERIC FAB, ANTIBODY ENGINEERING, EVOLUTION OF LIGAND RECOGNITION, IMMUNE SYSTEM
4a6y:B (VAL2) to (SER119) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 | IMMUNE SYSTEM, ANTIBODY MULTISPECIFICITY, HUMORAL IMMUNE SYSTEM, COMPLEMENTARITY DETERMINING REGION FLEXIBILITY
3k80:B (VAL2) to (SER123) STRUCTURE OF ESSENTIAL PROTEIN FROM TRYPANOSOMA BRUCEI | RNA-EDITING, OB-FOLD, RNA-BINDING PROTEINS, IMMUNE SYSTEM, RNA BINDING PROTEIN
2zcl:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY | HUMAN PSA, ANTIBODIES, KALLIKREIN RELATED PEPTIDASES, PROSTATE CANCER, GLYCOPROTEIN, HYDROLASE, PROTEASE, SECRETED, SERINE PROTEASE, ZYMOGEN, IMMUNE SYSTEM
4olw:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54H IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54H, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4olx:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54L IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54L, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4olz:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54W IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54W, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4om0:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54Y IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE | VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54Y, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2zjs:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT | TRANSLOCON, SEC, PROTEIN-CONDUCTING-CHANNEL, MEMBRANE, PROTEIN TRANSPORT, TRANSLOCATION, TRANSMEMBRANE, TRANSPORT, PROTEIN TRANSPORT-IMMUNE SYSTEM COMPLEX
4osu:H (VAL2) to (SER130) CRYSTAL STRUCTURE OF HCMV GB-NEUTRALIZING SM5-1 FAB FRAGMENT | IMMUNOGLOBULIN, IMMUNE RESPONSE, HCMV NEUTRALIZATION, HCMV GLYCOPROTEIN B, IMMUNE SYSTEM
4ot1:H (VAL2) to (SER130) STRUCTURAL BASIS FOR THE RECOGNITION OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B BY THE NEUTRALIZING HUMAN ANTIBODY SM5-1 | IMMUNOGLOBULIN, PH DOMAIN, ANTIBODY-ANTIGEN RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2zpk:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE | MOUSE IGG FAB FRAGMENT IN COMPLEX WITH ANTIGEN PEPTIDE, IMMUNE SYSTEM
2zpk:I (ILE2) to (SER112) CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE | MOUSE IGG FAB FRAGMENT IN COMPLEX WITH ANTIGEN PEPTIDE, IMMUNE SYSTEM
4otx:H (VAL2) to (SER112) STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT | ANTIBODY, IMMUNE SYSTEM, LIPOPOLYSACCHARIDE, INTERNAL EPITOPE
4otx:I (VAL2) to (SER112) STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT | ANTIBODY, IMMUNE SYSTEM, LIPOPOLYSACCHARIDE, INTERNAL EPITOPE
1mam:H (VAL2) to (SER118) CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN | IMMUNOGLOBULIN
5czv:H (VAL2) to (SER115) CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20350 FAB | ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM
1mel:B (VAL2) to (SER132) CRYSTAL STRUCTURE OF A CAMEL SINGLE-DOMAIN VH ANTIBODY FRAGMENT IN COMPLEX WITH LYSOZYME | CAMEL SINGLE-DOMAIN ANTI-LYSOZYME, COMPLEX (ANTIBODY/ANTIGEN)
1mfa:H (VAL252) to (SER367) STRUCTURE OF A SINGLE-CHAIN FV FRAGMENT COMPLEXED WITH A CARBOHYDRATE ANTIGEN AT 1.7 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN
1mfb:H (VAL252) to (SER367) HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA | IMMUNOGLOBULIN
1mhh:B (GLN3) to (SER112) ANTIBODY-ANTIGEN COMPLEX | ANTIBODY-ANTIGEN COMPLEX, B CELL SUPERANTIGEN, IMMUNOGLOBULIN BINDING PROTEIN, IMMUNE SYSTEM
1mhh:D (GLN3) to (SER112) ANTIBODY-ANTIGEN COMPLEX | ANTIBODY-ANTIGEN COMPLEX, B CELL SUPERANTIGEN, IMMUNOGLOBULIN BINDING PROTEIN, IMMUNE SYSTEM
3klh:D (ILE2) to (VAL121) CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P) | HIV-1, REVERSE TRANSCRIPTASE, RT, AZT, AZT EXCISION, AZT RESISTANCE, RESISTANCE MECHANISM, AZT RESISTANCE MUTATIONS, P51/P66, NUCLEOSIDE INHIBITOR, AIDS, HIV, DNA POLYMERASE, NRTI, NUCLEOTIDE EXCISION, DNA-DIRECTED DNA POLYMERASE, MAGNESIUM, METAL-BINDING, MULTIFUNCTIONAL ENZYME, NUCLEASE, RNA-DIRECTED DNA POLYMERASE, TRANSFERASE, TRANSFERASE-DNA COMPLEX
5d1q:B (GLN1) to (SER112) ISDB NEAT2 BOUND BY CLONE D2-06 | ISDB NEAT2, IGVH1-69, GERMLINE ENCODED, IMMUNE SYSTEM
1mlc:D (VAL2) to (SER115) MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME | COMPLEX (ANTIBODY/ANTIGEN)
4p46:B (ALA1) to (LEU110) J809.B5 Y31A TCR BOUND TO IAB3K | TCR MHCII, IMMUNE SYSTEM
1mpa:H (VAL2) to (SER120) BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS | MURINE IMMUNOGLOBULIN IGG2A KAPPA, BACTERICIDAL ANTIBODY, EPITOPE P1.16 OF PORA FROM NEISSERIA MENINGITIDIS, COMPLEX (IMMUNOGLOBULIN/PEPTIDE)
5d5m:E (GLN2) to (GLN112) STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR | ANTIGEN, IMMUNE SYSTEM
4p9h:H (GLN1) to (SER112) CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2 | IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
1mvu:B (VAL2) to (PRO120) SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE | SINGLE CHAIN FV, MONOCLONAL ANTIBODY, C219, P-GLYCOPROTEIN, IMMUNOGLOBULIN, SITE-DIRECTED MUTAGENESIS, IMMUNE SYSTEM
5d93:C (VAL2) to (VAL114) OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY | ENZYME, INHIBITOR, THIOREDOXIN FOLD, ANTIBODY, OXIDOREDUCTASE
5d93:F (VAL2) to (VAL114) OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY | ENZYME, INHIBITOR, THIOREDOXIN FOLD, ANTIBODY, OXIDOREDUCTASE
5d96:J (GLN3) to (SER117) OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1 | ENZYME, INHIBITOR, ANTIBODY, DUAL-SPECIFICITY, IMMUNE SYSTEM
1mwa:D (THR5) to (LEU316) 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX | IG DOMAIN, ANTIGEN RECOGNITION, COMPLEMENTARITY DETERMINING REGION, IMMUNE SYSTEM
1ymm:E (ALA2) to (VAL117) TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX | PROTEIN-PROTEIN COMPLEX, T CELL REPERTOIRE, AUTO-IMMUNITY, IMMUNE SYSTEM
3kyk:H (GLN3) to (SER118) CRYSTAL STRUCTURE OF LI33 IGG1 FAB | ANTIBODY, IMMUNE SYSTEM
3kym:D (GLN3) to (SER118) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kym:F (GLN3) to (SER118) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kym:H (GLN3) to (SER118) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
5dfw:H (ARG103) to (SER410) CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH SINGLE CHAIN FV FRAGMENT K13 | HELICAL BUNDLE, ANTIBODY-ANTIGEN COMPLEX, CELL ADHESION
1n64:H (ILE2) to (SER112) CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6 | ANTIBODY PEPTIDE COMPLEX, IMMUNE SYSTEM
5dk3:B (VAL2) to (SER119) CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY | CANCER, ANTIBODY, SUBCLASSES, IGG4, MELANOMA, IMMUNE SYSTEM
5dk3:G (VAL2) to (SER119) CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY | CANCER, ANTIBODY, SUBCLASSES, IGG4, MELANOMA, IMMUNE SYSTEM
3l5x:H (VAL2) to (SER120) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB | IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
1yyl:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M33, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1yym:R (VAL1002) to (SER1112) CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, F23, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5dmi:H (ILE2) to (SER112) STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB | CELL SURFACE RECEPTOR, ANTIBODY-ANTIGEN COMPLEX, ANTITUMOR, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX
4ps4:H (VAL2) to (SER120) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB | IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3lh2:K (VAL2) to (SER127) CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX | EPITOPE-SCAFFOLD, IMMUNE SYSTEM
3lhp:H (VAL2) to (SER126) CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX | EPITOPE-SCAFFOLD, IMMUNE SYSTEM
3lhp:I (VAL2) to (SER126) CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX | EPITOPE-SCAFFOLD, IMMUNE SYSTEM
1zea:H (ILE2) to (SER112) STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE | POLYSPECIFICITY, CROSS-REACTIVITY, ANTI-CHOLERA TOXIN, ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, SUBSTITUTION MATRIX, IMMUNE SYSTEM
4py7:I (GLN3) to (SER120) CRYSTAL STRUCTURE OF FAB 3.1 | IMMUNOGLOBULIN FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEMAGGLUTININ GLYCOPROTEINS, IMMUNE SYSTEM
1zgl:P (VAL4) to (GLU118) CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A | TCR/PEPTIDE/MHC COMPLEX, IMMUNE SYSTEM
4q2z:H (GLN3) to (SER112) FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE356, FROM A NON-HUMAN PRIMATE | FAB FRAGMENT, HIV VIRAL ENVELOPE GLYCOPROTEIN NEUTRALIZATION, IMMUNE SYSTEM
4q2z:A (GLN3) to (SER112) FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE356, FROM A NON-HUMAN PRIMATE | FAB FRAGMENT, HIV VIRAL ENVELOPE GLYCOPROTEIN NEUTRALIZATION, IMMUNE SYSTEM
3lrs:H (GLU2) to (SER112) STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1 | NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM
3lrs:A (GLU2) to (SER112) STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1 | NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM
4b5e:A (GLN3) to (VAL125) CRYSTAL STRUCTURE OF AN AMYLOID-BETA BINDING SINGLE CHAIN ANTIBODY PS2-8 | IMMUNE SYSTEM, VHH, ALZHEIMER'S DISEASE
3be1:H (GLN3) to (VAL113) DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2 | FAB COMPLEX, ATP-BINDING, GLYCOPROTEIN, KINASE, MEMBRANE, NUCLEOTIDE- BINDING, PHOSPHORYLATION, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE
3mlt:E (GLN3) to (SER112) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mlt:I (GLN3) to (SER112) CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE | HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM
3mnv:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT | HIV-1, HIV, GP41, MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3mnv:D (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT | HIV-1, HIV, GP41, MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3mnw:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE IN A HELICAL CONFORMATION | HIV-1, HIV GP41, MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3mnz:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE BEARING ALA SUBSTITUTIONS IN A HELICAL CONFORMATION | HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
3mo1:B (ILE2) to (SER112) CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT | HIV-1, HIV, GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM
4qth:H (VAL2) to (SER121) CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12 | ANTIBODY, IMMUNE SYSTEM
4qth:A (VAL2) to (SER121) CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12 | ANTIBODY, IMMUNE SYSTEM
3mug:F (GLU2) to (SER112) CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY | PG16, FAB, SULFOTYROSINE, HIV, IMMUNE SYSTEM
3bqu:B (ARG1) to (SER131) CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX | BETA SHEET, IMMUNE SYSTEM
5f3h:E (VAL2) to (SER115) STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f3h:G (VAL2) to (SER115) STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
4qxu:H (VAL2) to (SER117) NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY | STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IGG FOLD, IMMUNE SYSTEM
5f3j:C (GLN172) to (VAL287) CRYSTAL STRUCTURE OF DBP IN COMPLEX WITH INHIBITORY MONOCLONAL ANTIBODY 2D10 | PLASMODIUM, VIVAX, DUFFY BINDING PROTEIN, DBP, ANTIBODY, MALARIA, SCFV, NEUTRALIZING, INTERACTION, IMMUNE, BLOCKING, INVASION, VACCINE, THERAPEUTIC, IMMUNE SYSTEM
4qy8:A (GLN1) to (VAL112) CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8) IN COMPLEX WITH 3D7-MSP2 14-30 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, N-TERMINAL MSP2, UNSTRUCTURED ANTIGEN
5f7e:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF 3BNC60 FAB | ANTIBODY, IMMUNE SYSTEM, HIV-1
4buh:B (VAL2) to (SER125) HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV | IMMUNE SYSTEM, ANTIBODY, ALLERGEN
3c2a:I (GLN3) to (VAL111) ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE | ANTIBODY FAB HIV-1 PEPTIDE, ENVELOPE PROTEIN, IMMUNE SYSTEM
4r4n:W (GLN1) to (VAL111) CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120 | HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
4r7d:G (GLN1) to (VAL116) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:Q (GLN1) to (VAL116) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
3n9g:H (VAL2) to (SER122) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI- WEST NILE VIRUS MAB CR4354 | FAB FRAGMENT, HUMAN NEUTRALIZING ANTIBODY, MAB CR4354, IMMUNE SYSTEM, ANTI-WEST NILE VIRUS
3na9:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB15 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3nab:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB15 MUT6 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3nac:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB15 MUT7 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
4r8w:H (GLN3) to (SER125) CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A NEUTRALIZING ANTIBODY CT149 | INFLUENZA A VIRUS, HEMAGGLUTININ, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
4r96:B (VAL2) to (VAL117) STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET | IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET
4r96:F (VAL2) to (VAL117) STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET | IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET
4r96:H (VAL2) to (VAL117) STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET | IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET
4r9y:H (GLN2) to (VAL117) CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4 | KKO, PF4, HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM-CYTOKINE COMPLEX
3ncj:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB15 MUT8 | ANTIBODY, IMMUNE SYSTEM
3cfk:N (VAL2) to (GLY104) CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM | IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION
3nfs:H (VAL2) to (SER115) CRYSTAL STRUCTURE THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB | IL-2RA, CD25, DACLIZUMAB, ZENAPAX, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM
4rgm:H (GLN3) to (VAL119) STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1 | NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX
4rgm:C (GLN3) to (SER120) STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1 | NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX
3clf:H (ALA2) to (SER112) HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23 | HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3nn8:C (VAL2) to (VAL120) CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5 | BETA BARREL, ANTIBODY FRAGMENT, IMMUNOGLOBULIN, IMMUNE SYSTEM
3nn8:G (VAL2) to (SER121) CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5 | BETA BARREL, ANTIBODY FRAGMENT, IMMUNOGLOBULIN, IMMUNE SYSTEM
4ris:L (ASN1) to (THR105) STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK | ANTIBODY, IGG FOLD, IMMUNE SYSTEM, HIV-1 GP120 V2 REGION
4cad:E (VAL2) to (SER124) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
3nps:B (GLU1) to (SER112) CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4 | HYDROLASE, ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME-INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, MEMBRANE, SERINE PROTEASE, SIGNAL-ANCHOR, TRANSMEMBRANE, HYDROLASE - IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
5fuo:H (GLN3) to (SER120) EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE | IMMUNE SYSTEM, ANTI-ALBUMIN, FAB FRAGMENT, SERUM HALF-LIFE, FCRN, HUMAN SERUM ALBUMIN
3nz8:A (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8 | ANTIGEN BINDING, ANTIBODY, FAB, IMMUNOLOGICAL, HIV-2, V3, GP125, IMMUNE SYSTEM
3o2v:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE, AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY | IGG ANTIBODY FAB, IMMUNE SYSTEM
3o2w:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG | IGG ANTIBODY FAB, IMMUNE SYSTEM
4cmh:B (VAL2) to (SER119) CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984 | HYDROLASE-IMMUNE SYSTEM COMPLEX, MULTIPLE MYELOMA
4cni:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6 | IMMUNE SYSTEM, CDP6038, INTERLEUKIN 6
3o6m:H (VAL2) to (SER116) ANTI-TAT HIV 11H6H1 FAB' COMPLEXED WITH A 9-MER TAT PEPTIDE | ANTIGEN-BINDING SITE, U-SHAPED GROOVE, IMMUNE SYSTEM, TAT HIV
4tnw:J (GLU1) to (SER121) C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION | MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
5ggr:A (GLN3) to (SER112) PD-1 IN COMPLEX WITH NIVOLUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5ggs:A (VAL2) to (SER119) PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5ggs:C (VAL2) to (SER119) PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB | ANTIBODY, IMMUNE SYSTEM
4tuj:C (VAL2) to (SER112) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN. | ANTIBODY, NEUROBLASTOMA, IMMUNE SYSTEM
4tul:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN. | IMMUNE SYSTEM, NEUROBLASTOMA
4tuo:C (GLN3) to (SER112) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN. | NEUROBLASTOMA, IMMUNE SYSTEM
5gs0:F (GLN3) to (THR119) CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY | DIABODY, ANTIBODY FRAGMENT, COMPLEX, IMMUNE SYSTEM
5gs2:D (GLN3) to (SER120) CRYSTAL STRUCTURE OF DIABODY COMPLEX WITH REPEBODY AND MBP | DIABODY, ANTIBODY FRAGMENT, COMPLEX, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX
5gxb:B (GLN3) to (VAL127) CRYSTAL STRUCTURE OF A LACY/NANOBODY COMPLEX | TRANSPORTER, TRANSPORT PROTEIN
3dro:B (ARG1) to (ILE111) CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN GROWN IN AMMONIUM SULFATE | HIV-1, GP41, 2F5, NMAB, IMMUNE SYSTEM
4d9r:H (VAL2) to (SER120) INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D | FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
4d9r:E (VAL2) to (SER120) INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D | FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
3p0g:B (GLN3) to (VAL118) STRUCTURE OF A NANOBODY-STABILIZED ACTIVE STATE OF THE BETA2 ADRENOCEPTOR | BETA-2 ADRENOCEPTOR, AGONIST, NANOBODY, 7TM, GPCR, MEMBRANE, SIGNALING PROTEIN, HYDROLASE, MEMBRANE PROTEIN
3p0v:I (GLN3) to (SER112) ANTI-EGFR/HER3 FAB DL11 ALONE | BETA-SANDWICH, IMMUNE SYSTEM, ANTIGENS EGFR AND HER3
3p30:H (GLN3) to (SER112) CRYSTAL STRUCTURE OF THE CLUSTER II FAB 1281 IN COMPLEX WITH HIV-1 GP41 ECTODOMAIN | HIV, GP41, CLUSTER 2, FAB, 6-HELIX BUNDLE, IMMUNE SYSTEM
4dn3:H (GLU3) to (SER118) CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888 | ANTIBODY, IMMUNE SYSTEM
4ubd:C (VAL2) to (VAL124) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:Y (VAL2) to (VAL124) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:G (VAL2) to (SER125) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:S (VAL2) to (SER125) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:O (VAL2) to (VAL124) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4ubd:K (VAL2) to (VAL124) CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA | HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5i16:H (PCA1) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i16:B (PCA1) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1j:H (GLN3) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1l:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1l:B (VAL2) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4uok:A (GLN221) to (SER333) ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 3B4C-4 | IMMUNE SYSTEM, VIRAL PROTEIN, ALPHAVIRUS, VENEZUELAN, ANTIBODY NEUTRALIZATION, FAB
5i8e:A (GLU2) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING HIV-1 FUSION PEPTIDE- TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5i9q:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120 | ANTIBODY, IMMUNE SYSTEM, HIV-1
3pp3:H (VAL2) to (SER118) EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES | ANTIBODY FAB-FRAGMENT IG-DOMAIN, ANTIBODY, CD20, IMMUNE SYSTEM
3pp3:I (VAL2) to (SER118) EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES | ANTIBODY FAB-FRAGMENT IG-DOMAIN, ANTIBODY, CD20, IMMUNE SYSTEM
5ibu:G (VAL2) to (SER124) 6652 FAB (UNBOUND) | ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM
5ibu:H (VAL2) to (SER124) 6652 FAB (UNBOUND) | ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM
3pqy:J (MET2) to (LEU123) CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224 | H2DB, INFLUENZA, TCR, T CELL, PA EPITOPE, REPERTOIRE, VIRAL IMMUNITY, CHIMERIC TCR, IMMUNE SYSTEM
5igx:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF NIH45-46 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM1DELTAV1-3 GP120 | ANTIBODY, IMMUNE SYSTEM, HIV-1
4ut9:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM, SCFV FRAGMENT
4ut9:I (VAL2) to (SER112) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM, SCFV FRAGMENT
4ut9:J (VAL2) to (SER112) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM, SCFV FRAGMENT
4ut9:K (VAL2) to (SER112) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM, SCFV FRAGMENT
4uta:I (GLN3) to (SER121) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY
4eiz:C (GLN3) to (SER127) STRUCTURE OF NB113 BOUND TO APODHFR | NADP BINDING, OXIDOREDUCTASE-IMMUNE SYSTEM COMPLEX
5ip4:B (VAL4) to (SER112) X-RAY STRUCTURE OF THE C-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN | DCX DOMAIN, UBIQUITIN-LIKE FOLD, MICROTUBULE ASSOCIATED, SIGNALING PROTEIN, TRANSFERASE
4eow:H (VAL2) to (SER126) CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007 | IMMUNSYSTEM, ALPHA-HELICAL STRETCH IN CDR3-H, PROTEIN-DOCKING, IMMUNOGLOBULIN IGG1 (LAMBDA), AUTOANTIBODY CAUSING PAP, GM-CSF, IMMUNE SYSTEM
3q6f:A (TYR2) to (VAL106) CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120 | IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM
3q6f:E (TYR2) to (VAL106) CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120 | IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM
3q6f:G (TYR2) to (VAL106) CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120 | IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM
3q6g:M (TYR2) to (VAL106) CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120 | IG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM
3qdg:D (LYS1) to (LYS108) THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE | MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, CROSS- REACTIVITY, MELANOMA, CANCER, IMMUNE SYSTEM
3qeh:C (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY | ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM
3qeh:G (VAL2) to (SER112) CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY | ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM
4f33:B (VAL2) to (SER118) CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 | IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM
4f33:D (VAL2) to (SER118) CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 | IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM
4f33:F (VAL2) to (SER118) CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 | IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM
4f33:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 | IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM
5j3h:C (VAL2) to (VAL116) HUMAN INSULIN RECEPTOR DOMAINS L1-CR IN COMPLEX WITH PEPTIDE S519C16 AND 83-7 FV | INSULIN RECEPTOR INSULIN MIMETIC PEPTIDE FV FRAGMENT, HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX
3qpq:J (VAL2) to (SER118) CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3
4w6x:B (VAL2) to (SER124) CO-COMPLEX STRUCTURE OF THE LECTIN DOMAIN OF F18 FIMBRIAL ADHESIN FEDF WITH INHIBITORY NANOBODY NBFEDF7 | LECTIN, FIMBRIAE, CELL ADHESION, INHIBITOR
3r1g:H (GLN3) to (SER114) STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE- BINDING ANTIBODY | ASPARTAL PROTEASE, PROTEIN BINDING
3rev:A (SER4) to (GLN119) CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20 | T CELL RECEPTOR, MHC CLASS I, TUMOUR ANTIGEN, IMMUNE SYSTEM, IMMUNE RESPONSE, ALLOREACTIVITY, IMMUNOGLOBULIN DOMAIN
4fqh:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB CR9114 | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM
5jxe:D (VAL2) to (SER119) HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB | HUMAN PD-1 PEMBROLIZUMAB FAB, IMMUNE SYSTEM
5jxe:G (VAL2) to (SER119) HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB | HUMAN PD-1 PEMBROLIZUMAB FAB, IMMUNE SYSTEM
4g6a:C (GLN2) to (VAL111) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
5kan:J (VAL2) to (SER127) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | INFLUENZA, MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
4gay:H (VAL2) to (SER112) STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 | ANTIBODY FAB, NEUTRALIZING ANTIBODY, HCV E2, IMMUNE SYSTEM
4gay:A (VAL2) to (VAL111) STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 | ANTIBODY FAB, NEUTRALIZING ANTIBODY, HCV E2, IMMUNE SYSTEM
4gmt:I (VAL2) to (SER112) CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 | FAB, FRAGMENT ANTIGEN BINDING, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
5kn5:A (VAL2) to (SER117) TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859 | TGFALPHA EPIREGULIN ANTIBODY FAB, IMMUNE SYSTEM
5kn5:D (VAL2) to (SER117) TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859 | TGFALPHA EPIREGULIN ANTIBODY FAB, IMMUNE SYSTEM
4gqp:H (GLU1) to (SER112) STRUCTURE BASED DESIGN OF SUB-NANOMOLAR AFFINITY ANTI-METHAMPHETAMINE SINGLE CHAIN ANTIBODIES. | ANTIBODY METH COMPLEX, IMMUNOGLOBULIN FOLD, ANTI-METH SINGLE CHAIN ANTIBODY, FREE METH CONCENTRATION, METHAMPHETAMINE, VASCULATURE, IMMUNE SYSTEM
5kvd:H (VAL2) to (SER112) ZIKA SPECIFIC ANTIBODY, ZV-2, BOUND TO ZIKA ENVELOPE DIII | ZIKA VIRUS, ENVELOPE DIII, VIRAL PROTEIN, ANTIBODY, IGG2C, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5kvg:H (GLN3) to (SER112) ZIKA SPECIFIC ANTIBODY, ZV-67, BOUND TO ZIKA ENVELOPE DIII | ZIKA VIRUS, ENVELOPE PROTEIN, VIRAL PROTEIN, ANTIBODY, STRUCTURAL GENOMICS, CSGID, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5lbs:H (VAL2) to (SER112) STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ZIKA VIRUS, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN
5ljy:H (GLN3) to (VAL111) STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN COMPLEX WITH SCFV A5 | HANTAVIRUS, GLYCOPROTEIN, VIRAL FUSION, VIRAL PROTEIN
5ljy:L (LEU4) to (LEU106) STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN COMPLEX WITH SCFV A5 | HANTAVIRUS, GLYCOPROTEIN, VIRAL FUSION, VIRAL PROTEIN
5tfs:H (GLN3) to (SER112) STRUCTURE OF CHIMERIC 02-K FAB, A VRC01-LIKE GERMLINE ANTIBODY | FAB, HIV-1, VRC01, CDRH3, CD4-BS, VH1-2, IMMUNE SYSTEM
1a4j:H (VAL2) to (SER118) DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR | IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE
1a4j:B (VAL2) to (SER118) DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR | IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE
1nc2:B (VAL2) to (SER118) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA | ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, YTTRIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
1nc2:D (LYS3) to (VAL117) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA | ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, YTTRIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM
1nfd:E (TYR2) to (ARG107) AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY | COMPLEX (IMMUNORECEPTOR-IMMUNOGLOBULIN), COMPLEX (IMMUNORECEPTOR- IMMUNOGLOBULIN) COMPLEX
1nlb:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6 | MURINE MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3eo1:B (VAL2) to (SER119) STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3 | ANTIBODY-CYTOKINE COMPLEX, GROWTH FACTOR, FAB FRAGMENT, CARDIOMYOPATHY, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, MITOGEN, POLYMORPHISM, SECRETED, IMMUNE SYSTEM/CYTOKINE COMPLEX
3eo1:E (VAL2) to (SER119) STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3 | ANTIBODY-CYTOKINE COMPLEX, GROWTH FACTOR, FAB FRAGMENT, CARDIOMYOPATHY, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, MITOGEN, POLYMORPHISM, SECRETED, IMMUNE SYSTEM/CYTOKINE COMPLEX
3eo1:H (VAL2) to (SER119) STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3 | ANTIBODY-CYTOKINE COMPLEX, GROWTH FACTOR, FAB FRAGMENT, CARDIOMYOPATHY, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, MITOGEN, POLYMORPHISM, SECRETED, IMMUNE SYSTEM/CYTOKINE COMPLEX
3eo1:K (VAL2) to (SER119) STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3 | ANTIBODY-CYTOKINE COMPLEX, GROWTH FACTOR, FAB FRAGMENT, CARDIOMYOPATHY, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, MITOGEN, POLYMORPHISM, SECRETED, IMMUNE SYSTEM/CYTOKINE COMPLEX
4hfw:H (PHE2) to (SER119) ANTI ROTAVIRUS ANTIBODY | IG FOLD, IMMUNE RESPONSE, ROTAVIRUS VP6 PROTEIN, IMMUNE SYSTEM
4hfw:B (PHE2) to (SER119) ANTI ROTAVIRUS ANTIBODY | IG FOLD, IMMUNE RESPONSE, ROTAVIRUS VP6 PROTEIN, IMMUNE SYSTEM
4hg4:V (VAL2) to (VAL111) CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1c5d:H (VAL2) to (VAL115) THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR | IMMUNOGLOBULIN, IMMUNE SYSTEM
1p2c:E (VAL1202) to (SER1315) CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY | MONOCLONAL ANTIBODY IGG1, KAPPA ANTIBODY/ANTIGEN COMPLEX, IMMUNE SYSTEM/HYDROLASE COMPLEX
3g04:B (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY | TSH RECEPTOR, GPCR, THYROID, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR- AUTOANTIBODY COMPLEX, IMMUNE SYSTEM
1pg7:X (VAL2) to (SER112) MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB | IMMUNE SYSTEM
2r0z:H (VAL2) to (SER112) PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT | IMMUNOGLOBULIN; ALZHEIMER DISEASE; AMYLOID, IMMUNE SYSTEM
1q0x:H (VAL2) to (SER112) ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM | ANTI-MORPHINE ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
4jzj:A (VAL2) to (SER119) CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX | RECEPTOR-FAB COMPLEX, CYTOKINE RECEPTOR-IMMUNE SYSTEM COMPLEX
4yo0:A (VAL21) to (SER135) CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE | ANTIBODIES, MONOCLONAL, ANTIBODY AFFINITY, CHROMATOGRAPHY, AFFINITY, EPITOPES, RATS, IMMUNOGLOBULIN FAB FRAGMENTS, KINETICS, PEPTIDES, PROTEIN BINDING, PROTEINS, RECOMBINANT FUSION PROTEINS, HUMAN PODOPLANIN, IMMUNE SYSTEM
1fl5:H (VAL2) to (SER112) THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4. | CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM
1fl5:B (VAL2) to (SER112) THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4. | CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM
2vdm:H (VAL2) to (SER118) RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN | CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX
4kmt:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
3uze:B (LYS3) to (SER116) CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11 | DENGUE ANTIBODY NEUTRALIZATION, IMMUNE SYSTEM
1ghf:H (VAL1) to (SER114) ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT | ANTIBODY FAB FRAGMENT
4kq3:H (VAL2) to (SER116) CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1sjx:A (GLN801) to (SER918) THREE-DIMENSIONAL STRUCTURE OF A LLAMA VHH DOMAIN OE7 BINDING THE CELL WALL PROTEIN MALF1 | CAMELIDS ANTIBODY, HEAVY CHAIN, DANDRUFF, PHAGE DISPLAY, IMMUNE SYSTEM
4kxz:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008. | CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM
4kxz:J (VAL2) to (SER119) CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008. | CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM
4kxz:N (VAL2) to (SER119) CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008. | CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM
4kxz:Q (VAL2) to (SER119) CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008. | CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM
3vi3:H (VAL2) to (VAL116) CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM) | BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX
2gki:A (VAL24) to (SER141) HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY | ANTI-DNA ANTIBODY, CATALYTIC ANTIBODY, IMMUNE SYSTEM
1tet:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS | IMMUNOGLOBULIN
3iu3:A (GLN1) to (SER114) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN | IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM
1tqb:B (ILE2) to (SER112) OVINE RECOMBINANT PRP(114-234), VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY | PRION, ANTIBODY, UNKNOWN FUNCTION/IMMUNE SYSTEM COMPLEX
4lmq:H (VAL2) to (VAL111) DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12 | IMMUNOGLOBULIN, CELL ADHESION-IMMUNE SYSTEM COMPLEX
4lvo:C (VAL2) to (SER119) CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2 | ALPHA BETA, ENZYME-PRODOMAIN COMPLEX, ROSSMANN FOLD, SERINE PROTEASE, CALCIUM IONS, PRODOMAIN, PARASITOPHOROUS VACUOLE, HYDROLASE- INHIBITOR-IMMUNE SYSTEM COMPLEX
1igi:H (VAL2) to (SER112) 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY | IMMUNOGLOBULIN
3j1s:H (LEU5) to (SER119) STRUCTURE OF ADENO-ASSOCIATED VIRUS-2 IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY A20 | EPITOPE, FAB, GENE THERAPY, VIRUS-IMMUNE SYSTEM COMPLEX
1jgl:H (ILE2) to (SER112) CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL | ANTIBODY, FOUR-CENTER HYDROGEN BOND, STEROID, IMMUNE SYSTEM
3wsq:L (GLN1) to (LEU107) STRUCTURE OF HER2 WITH AN FAB | KINASE, TRANSFERASE-IMMUNE SYSTEM COMPLEX
3x3f:H (VAL2) to (SER125) TRAIL-R2 EXTRACELLULAR REGION COMPLEXED TO A FAB FRAGMENT FROM HUMAN AGONIST ANTIBODY KMTR2 | TRAIL-R2, AGONIST ANTIBODY, APOPTOSIS-IMMUNE SYSTEM COMPLEX
2y6s:D (VAL2) to (SER112) STRUCTURE OF AN EBOLAVIRUS-PROTECTIVE ANTIBODY IN COMPLEX WITH ITS MUCIN-DOMAIN LINEAR EPITOPE | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
2y6s:H (VAL2) to (SER112) STRUCTURE OF AN EBOLAVIRUS-PROTECTIVE ANTIBODY IN COMPLEX WITH ITS MUCIN-DOMAIN LINEAR EPITOPE | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4o5i:Q (GLU1) to (SER112) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ | IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3jwo:H (VAL2) to (SER112) STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY | HIV-1 VIRAL SPIKE, MOLECULAR MOTION, PROTEIN ARCHITECTURE, RECEPTOR- TRIGGERED ENTRY, TYPE 1 FUSION PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, VIRAL PROTEIN
2ny2:D (GLU3001) to (SER3127) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2z93:C (GLN3) to (SER112) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C-ABCD | IMMUNOGLOBURIN LIKE FOLD, IMMUNE SYSTEM
1mfe:H (VAL252) to (SER367) RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT | IMMUNOGLOBULIN
1mfc:H (VAL252) to (SER367) HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA | IMMUNOGLOBULIN
1mfd:H (VAL252) to (SER367) THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE | IMMUNOGLOBULIN
1mlb:B (VAL2) to (SER115) MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME | IMMUNOGLOBULIN, IMMUNE SYSTEM
1ymh:D (GLN3) to (SER112) ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W | ENGINEERING OF CRYSTAL CONTACTS, PPL-FAB COMPLEX, IMMUNE SYSTEM
5dfv:E (VAL102) to (SER410) CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04 | HELICAL BUNDLE, CELL ADHESION, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM
4pir:F (ASP1) to (VAL122) X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR | MEMBRANE TRANSPORT, ION CHANNEL, TRANSPORT PROTEIN
1n4x:I (VAL302) to (SER419) STRUCTURE OF SCFV 1696 AT ACIDIC PH | IMMUNOGLOBULIN, IMMUNE SYSTEM
5drn:A (GLN3) to (SER112) CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE | HYPUSINE, ANTIBODY, FABHPU24, EIF5A, IMMUNE SYSTEM
2adf:H (ILE2) to (SER117) CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN | ON WILLEBRAND FACTOR, A3-DOMAIN, 82D6A3, COLLAGEN BINDING, PARATOPE, EPITOPE, ANTITHROMBOTIC, BLOOD CLOTTING-IMMUNE SYSTEM COMPLEX
5f21:B (GLN3) to (SER120) HUMAN CD38 IN COMPLEX WITH NANOBODY MU375 | CD38, ADP-RIBOSYL CYCLASE, CYCLIC ADP-RIBOSE, X-CRYSTALLOGRAPHY, CALCIUM SIGNALING, NANOBODY, MU375, HYDROLASE-IMMUNE SYSTEM COMPLEX
3naa:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF FAB15 MUT5 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
4rir:H (VAL2) to (SER113) STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK | ANTIBODY, IGG FOLD, IMMUNE SYSTEM, HIV-1 GP120 V2 REGION
4rir:A (VAL2) to (SER113) STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK | ANTIBODY, IGG FOLD, IMMUNE SYSTEM, HIV-1 GP120 V2 REGION
5fuz:H (GLN3) to (SER120) EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE | IMMUNE SYSTEM, ANTI-ALBUMIN, FAB FRAGMENT, SERUM HALF-LIFE, FCRN, HUMAN SERUM ALBUMIN
4d9q:E (VAL2) to (SER120) INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D | FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
4d9q:H (VAL2) to (SER120) INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D | FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
4dn4:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO888 FAB AND MCP-1 MUTANT P8A | ANTIBODY CHEMOKINE, IMMUNE SYSTEM
5i1k:H (VAL2) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3piq:L (TYR2) to (VAL106) CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1 | MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM
4e41:J (VAL2) to (GLU110) STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4 | IG DOMAIN, ADAPTIVE IMMUNITY, T CELL RECEPTOR, MHC, IMMUNE SYSTEM
3qcu:H (VAL2) to (SER112) CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0) | ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM
3qq9:H (VAL2) to (SER119) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F | IMMUNE SYSTEM, RSV F PROTEIN
3r06:F (VAL2) to (SER112) CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT | ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM
3rdt:B (ALA1) to (LEU110) CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE | MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM
5js9:E (ILE2) to (SER131) UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128 | HIV-1 TRIMER, UFO, SOSIP, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5jsa:E (ILE2) to (SER131) UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128 | HIV-1 TRIMER, UFO, SOSIP, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX